SUBSCRIBE
SUBSCRIBE
News   Deals

Myriad Genetics, Inc. Hires JPMorgan to Explore Splitting Business

August 20, 2008 | 
1 min read
Aug. 19 (Bloomberg) -- Myriad Genetics Inc. hired the investment bank JPMorgan Chase & Co. to explore separating Myriad's drug-development and genetic-testing businesses after its experimental treatment for Alzheimer's disease failed.
Mergers & acquisitions People
MORE ON THIS TOPIC
Concept of saving money with a pink colored piggy bank held in a hand in front of a blackboard with hand drawn coins
Neuroscience
Servier Bets $450M On Kaerus’ Fragile X Syndrome Therapy
September 8, 2025
 · 
2 min read
 · 
Tristan Manalac
Changing or transforming, turning around, challenging the odds and conquering adversity, a businessman pole vaulting from the down arrow to the up arrow of growth
IPO
SPACs Line Up To Clear Biotech’s IPO Backlog
September 3, 2025
 · 
6 min read
 · 
Annalee Armstrong
A red paper airplane with a fighter jet shadow changes course from a group of other paper airplanes, a concept of different business and social behaviors. Vector illustration.
IPO
After Short Stint as a Private Company, BBOT Leaves SPAC Process Ready To Execute
September 3, 2025
 · 
3 min read
 · 
Annalee Armstrong
FDA
Offit Out at FDA Vaccine Advisory Committee After HHS Rebuff
September 2, 2025
 · 
3 min read
 · 
Heather McKenzie